Gilead Sciences seeks marketing authorisation from India for potential COVID-19 drug remdesivir
NE BUSINESS BUREAU NEW DELHI, MAY 30 US pharma giant Gilead Sciences has applied to India's drug regulator, seeking marketing ...
Tag: New Drug and Clinical Trial Rules 2019
